ArticleJournal of experimental & clinical cancer research : CR2023
Correction: Complement inhibitor CSMD1 modulates epidermal growth factor receptor oncogenic signaling and sensitizes breast cancer cells to chemotherapy.
Chrysostomi Gialeli et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.